Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer.
Adrienne G WaksTanya E KeenanTianyu LiNabihah TayobGerburg M WulfEdward T RichardsonVictoria AttayaLeilani AndersonElizabeth A MittendorfBeth OvermoyerEric P WinerIan E KropJudith AgudoEliezer Van AllenSara M TolaneyPublished in: Journal for immunotherapy of cancer (2022)
NCT03032107.